KIORA PHARMACEUTICALS INC
Profile
Company Names
KIORA PHARMACEUTICALS INC
EYEGATE PHARMACEUTICALS INC
Addresses
169 SAXONY RD., SUITE 212, ENCINITAS, CA 92024
332 ENCINITAS BOULEVARD, SUITE 102, ENCINITAS, CA 92024
271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA 02452
271 WAVERLEY OAKS ROAD, SUITE 108, WALTHAM, MA 02452
271 WAVERLY OAKS ROAD, SUITE 108, WALTHAM, MA 02452
100 BEAVER STREET, WALTHAM, MA 02453
Phone Numbers
858-224-9600
781-788-9043
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY
Year Incorporated:
2004
State Incorporated:
DELAWARE
Total Amount Raised:
$68,468,598.00
Number of Funding Rounds:
16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2026-04-06
$5,000,000.00
$5,000,000.00
$0.00
Equity
15
2024-02-05
$15,000,000.00
$15,000,000.00
$0.00
Equity
14
2023-02-03
$200,000.00
$200,000.00
$0.00
Equity
13
2021-10-21
$67,258.00
INDEFINITE
INDEFINITE
Equity
12
2021-08-09
$10,750,013.00
$10,750,013.00
$0.00
11
2021-01-06
$8,000,003.00
$8,000,003.00
$0.00
Equity
10
2020-12-18
$3,203,083.00
INDEFINITE
INDEFINITE
Equity
9
2020-01-03
$0.00
INDEFINITE
INDEFINITE
8
2019-10-02
$1,875,000.00
$1,875,000.00
$0.00
Equity
7
2016-06-30
$3,768,750.00
$3,768,750.00
$0.00
6
2016-03-07
$2,618,797.00
$2,618,797.00
$0.00
Equity
5
2014-06-06
$994,843.00
$2,000,000.00
$1,005,157.00
Debt
4
2013-07-29
$968,971.00
$1,448,264.00
$479,293.00
Debt
3
2010-12-30
$4,450,648.00
$4,450,648.00
$0.00
Equity
2
2009-12-08
$11,081,232.00
$22,641,695.00
$11,560,463.00
Equity
1
2009-10-30
$490,000.00
$490,000.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
STEVEN
BOYD
DIRECTOR
TIGER GLOBAL FB PARTNERS, LLC
| ARMISTICE CAPITAL FUND LP
| ARMISTICE CAPITAL FUND OFFSHORE LTD.
| REVERSE MORTGAGE INVESTMENT TRUST INC.
| ARMISTICE CAPITAL OFFSHORE FUND LTD.
| EYEGATE PHARMACEUTICALS INC
| AYTU BIOSCIENCE, INC
| TETRAPHASE PHARMACEUTICALS INC
| TREBUCHET GRANITE ONSHORE FUND, LP
| TENAX THERAPEUTICS, INC.
| VARSITY EMERGENCY CARE HOLDINGS, LLC
PAUL
CHANEY
DIRECTOR
ERIC
DANIELS
EXECUTIVE OFFICER
PETER
GREENLEAF
DIRECTOR
THOMAS
HANCOCK
DIRECTOR
THOMAS
E.
HANCOCK
DIRECTOR
DAVID
HOLLANDER
DIRECTOR
KEITH
MAHER
DIRECTOR
MICHAEL
MULLEN
DIRECTOR
EYEGATE PHARMACEUTICALS INC
| INNOVATION X HOLDINGS, LLC
| INNOVATION X HOLDINGS QP, LLC
| NSC BIOTECH OPPORTUNITIES QP FUND, LLC
| NSC BIOTECH OPPORTUNITIES FUND, LLC
| INNOVATION X HOLDINGS QP, LLC - SERIES 2018-1
| INNOVATION X HOLDINGS QP, LLC - SERIES 2019-1
| INNOVATION X HOLDINGS QP - SERIES 2018-6B
| REACTIVECORE, INC.
| INNOVATION X HOLDINGS SERIES 2020-1 QP, LLC
| INNOVATION X HOLDINGS SERIES 2020-2 QP, LLC
| NAM SPECIAL SITUATIONS FUND I QP, LLC - SERIES F1
| B. RILEY PRIVATE SHARES FUND 2022-1 QP, LLC
| B. RILEY PRIVATE SHARES FUND 2022-1, LLC
| B. RILEY PRIVATE SHARES FUND 2023-1, LLC
| B. RILEY PRIVATE SHARES 2023-2 QC, LLC
| B. RILEY PRIVATE SHARES 2023-2 QP, LLC
| B. RILEY PRIVATE SHARES FUND 2023-3, LLC
SARAH
ROMANO
EXECUTIVE OFFICER
ARON
SHAPIRO
DIRECTOR
BRIAN
STREM
EXECUTIVE OFFICER, DIRECTOR
PRAVEEN
TYLE
DIRECTOR
LISA
WALTERS-HOFFERT
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2026-04-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-05
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-02-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-10-21
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2021-01-06
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-18
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-10-02
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2016-03-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-06-06
